Danone (OTCMKTS:DANOY) Share Price Passes Below Fifty Day Moving Average – Should You Sell?

Danone (OTCMKTS:DANOYGet Free Report)’s share price passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $17.02 and traded as low as $16.42. Danone shares last traded at $16.47, with a volume of 724,359 shares trading hands.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Kepler Capital Markets upgraded Danone to a “strong-buy” rating in a report on Wednesday, February 11th. Morgan Stanley reiterated an “overweight” rating on shares of Danone in a research note on Monday, February 23rd. Finally, Deutsche Bank Aktiengesellschaft cut shares of Danone from a “hold” rating to a “sell” rating in a report on Monday, January 12th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy”.

View Our Latest Analysis on DANOY

Danone Price Performance

The company has a 50 day moving average price of $17.02 and a 200 day moving average price of $17.44. The company has a current ratio of 0.95, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66.

About Danone

(Get Free Report)

Danone is a French multinational food-products company headquartered in Paris, with roots dating to 1919 when it was founded by Isaac Carasso. The company positions itself around nutrition and health-oriented food and beverage products, and it combines global brand management, manufacturing and distribution to serve a broad consumer base. Danone’s long history has been characterized by expansion beyond its original yogurt business into bottled water, infant and medical nutrition, and plant-based alternatives.

Danone’s principal activities include the development, production and marketing of dairy and plant-based products, bottled waters, and specialized nutrition for infants and medical patients.

Further Reading

Receive News & Ratings for Danone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danone and related companies with MarketBeat.com's FREE daily email newsletter.